LSL/MED/0253 The Supply of Nalaxone and Atropine

In April 2015 the MOD signed a thirteen year contract with Leidos Europe Ltd to provide the procurement and inventory management of commodity items (as well as the storage and distribution services) historically provided in-house by the Logistic Commodities and Services Operating Centre. Leidos, working with the MOD, will transform the way these services are delivered to ensure requirements continue to be met whilst providing best value for money for the department. The organisation delivering these services is known as Team Leidos. Team Leidos would like to make markets aware that we are intending to investigate innovative approaches to fill our Supply of Naloxone and Atropine requirements. We are interested in the following: Atropine: Preferred product would be 2mg/mL in a 50mL vial, but the key requirement is the 100mg of drug in one vial. Naloxone: Preferred product would be 2mg/mL in a 20mL vial. However, would accept 2mg/ml in 50ml vial (total dose of 100mg per vial). It is the aim of this Preliminary Market Engagement Notice (PMEN) to encourage companies, suppliers, or manufacturers to make us aware and provide as much information as they are comfortable with, to help decide the future strategy for the range. Team Leidos wishes to generate interest, information and views with other companies to understand the current market innovation and gain useful intelligence that can help our requirement. To request the PMEN documents please contact: Name and Email address Macy Johnson Macy.johnson248@teamleidos.mod.uk In the email request the documents related the Supply of Naloxone and Atropine. The documents will then be sent for completion and should be returned to the same email addresses before the deadline. Responses are required as soon as possible to inform next steps, but the PMEN will remain open until 06/11/2026